(a) In this section:
(1) “Provider pharmacy” means a Class A pharmacy that provides pharmacy services through a telepharmacy system at a remote dispensing site.
(2) “Remote dispensing site” means a location licensed as a telepharmacy that is authorized by a provider pharmacy through a telepharmacy system to store and dispense prescription drugs and devices, including dangerous drugs and controlled substances.
(3) “Telepharmacy system” means a system that monitors the dispensing of prescription drugs and provides for related drug use review and patient counseling services by an electronic method, including the use of the following types of technology:
(A) audio and video;
(B) still image capture; and
(C) store and forward.
(b) A Class A or Class C pharmacy located in this state may provide pharmacy services, including the dispensing of drugs, through a telepharmacy system at locations separate from the Class A or Class C pharmacy.

(c) A telepharmacy system is required to be under the continuous supervision of a pharmacist as determined by board rule. To qualify as continuous supervision for a telepharmacy system, the pharmacist is not required to be physically present at the site of the telepharmacy system. The pharmacist shall supervise the system electronically by audio and video communication.
(d) A telepharmacy system may be located only at:
(1) a health care facility in this state that is regulated by this state or the United States; or
(2) a remote dispensing site.
(e) The board shall adopt rules regarding the use of a telepharmacy system under this section, including:
(1) the types of health care facilities at which a telepharmacy system may be located under Subsection (d)(1), which must include the following facilities:
(A) a clinic designated as a rural health clinic regulated under 42 U.S.C. § 1395x(aa);
(B) a health center as defined by 42 U.S.C. § 254b; and
(C) a federally qualified health center as defined by 42 U.S.C. § 1396d(l)(2)(B);
(2) the locations eligible to be licensed as remote dispensing sites, which must include locations in medically underserved areas, areas with a medically underserved population, and health professional shortage areas determined by the United States Department of Health and Human Services;
(3) licensing and operating requirements for remote dispensing sites, including:
(A) a requirement that a remote dispensing site license identify the provider pharmacy that will provide pharmacy services at the remote dispensing site;
(B) a requirement that a provider pharmacy be allowed to provide pharmacy services at not more than two remote dispensing sites;
(C) a requirement that a pharmacist employed by a provider pharmacy make at least monthly on-site visits to a remote dispensing site or more frequent visits if specified by board rule;
(D) a requirement that each month the perpetual inventory of controlled substances at the remote dispensing site be reconciled to the on-hand count of those controlled substances at the site by a pharmacist employed by the provider pharmacy;
(E) a requirement that a pharmacist employed by a provider pharmacy be physically present at a remote dispensing site when the pharmacist is providing services requiring the physical presence of the pharmacist, including immunizations;
(F) a requirement that a remote dispensing site be staffed by an on-site pharmacy technician who is under the continuous supervision of a pharmacist employed by the provider pharmacy;
(G) a requirement that all pharmacy technicians at a remote dispensing site be counted for the purpose of establishing the pharmacist-pharmacy technician ratio of the provider pharmacy, which, notwithstanding Section 568.006, may not exceed three pharmacy technicians for each pharmacist providing supervision;
(H) a requirement that, before working at a remote dispensing site, a pharmacy technician must:
(i) have worked at least one year at a retail pharmacy during the three years preceding the date the pharmacy technician begins working at the remote dispensing site; and
(ii) have completed a board-approved training program on the proper use of a telepharmacy system;
(I) a requirement that pharmacy technicians at a remote dispensing site may not perform extemporaneous sterile or nonsterile compounding but may prepare commercially available medications for dispensing, including the reconstitution of orally administered powder antibiotics; and
(J) any additional training or practice experience requirements for pharmacy technicians at a remote dispensing site;
(4) the areas that qualify under Subsection (f);
(5) recordkeeping requirements; and
(6) security requirements.
(f) Except as provided by Subsection (f-1), a telepharmacy system located at a health care facility under Subsection (d)(1) may not be located in a community in which a Class A or Class C pharmacy is located as determined by board rule. If a Class A or Class C pharmacy is established in a community in which a telepharmacy system has been located under this section, the telepharmacy system may continue to operate in that community.
(f-1) A telepharmacy system located at a federally qualified health center as defined by 42 U.S.C. § 1396d(l)(2)(B) may be located in a community in which a Class A or Class C pharmacy is located as determined by board rule.